A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Issue: Sep/Oct 2021 - Volume 25, Number 5
View All Articles in Issue
Page(s): 417
Download in electronic PDF format for $65
Abstract: A formulation for preparing Haloperidol 0.5-mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr, PhD, RPh, haloperidol, formulation, oral suspension, antipsychotic agent, dyskinesis, antidyskinetic agent, Tourette syndrome, movement disorders, mood disorders, psychoses, schizophrenia, schizoaffective disorders, suicide, aggression, aggressive behavior, hallucinations